YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 15, 16:00
3776.40
56.15 (1.51%)
VOLUME 40,118
LIVE
NSE
Apr 15, 15:59
3783.40
64.95 (1.75%)
VOLUME 850,076
News on Divis Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Divis Q4 PAT seen up 41.1% YoY to Rs. 467.2 cr: Sharekhan

8.12 pm | 12 Apr 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 20.9 percent Y-o-Y (down 1.3 percent Q-o-Q) to Rs. 1,680 crore, according to Sharekhan....

Hot Stocks | Can bet on Divi's Laboratories, Cadila Healthcare, IG Petrochemicals for short term

7.48 am | 07 Apr 2021 |  Source: Moneycontrol.com

The next higher levels to be watched are around 14,800-14,900 for Nifty. Any pullback towards 14,600-14,500 should be used as a buying opportunity....

Buy Divi’s Lab; target of Rs 4530: Motilal Oswal

2.33 pm | 25 Mar 2021 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divi’s Lab recommended buy rating on the stock with a target price of Rs 4530 in its research report dated March 24, 202...

Hot Stocks | Divi's Labs, SBI and Ashok Leyland three trading ideas for the short term

7.15 am | 25 Mar 2021 |  Source: Moneycontrol.com

India VIX has currently settled below 22.45 on the daily chart so we can expect high volatility in the coming trading sessions....

Buy Divis Laboratories: target of Rs 4500: Sharekhan

3.40 pm | 24 Mar 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4500 in its research report dated March 2...

Gladiator Stocks - Divis Laboratories: ICICI Direct

3.05 pm | 22 Mar 2021 |  Source: Moneycontrol.com

According to ICICI Direct, Buy Divis Laboratories in the range of Rs 3280.00–3325.00 for target price of Rs 3740.00 with a stop loss of Rs 3110.00. ...

Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y

10.57 am | 05 Mar 2021 |  Source: Moneycontrol.com

NULL...

Buy Divi’s Laboratories; target of Rs 4440: ICICI Direct

3.30 pm | 10 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 4440 in its research report dated F...

Divis Labs Consolidated December 2020 Net Sales at Rs 1,701.44 crore, up 21.86% Y-o-Y

10.00 am | 09 Feb 2021 |  Source: Moneycontrol.com

NULL...

Divis Labs Standalone December 2020 Net Sales at Rs 1,656.48 crore, up 19.13% Y-o-Y

9.22 am | 09 Feb 2021 |  Source: Moneycontrol.com

NULL...

Divi’s Labs: All set to reap investments

9.54 am | 08 Feb 2021 |  Source: Moneycontrol.com

Since the macro context is fragile, eventually liquidity will continue to chase cash rich and cash flow positive businesses such as Divi’s Labs...

Buy Divi's Laboratories; target of Rs 4425: ICICI Direct

12.42 pm | 30 Dec 2020 |  Source: Moneycontrol.com

ICICI Securities is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4425 in its research report dated...

Buy Divis Laboratories: target of Rs 4175: Sharekhan

2.02 pm | 07 Dec 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 4175 in its research report dated December 04...

Buy Divis Laboratories: target of Rs 3800: Sharekhan

11.30 am | 11 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06...

Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal

12.12 pm | 10 Nov 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3900 in its research report dated Nove...

Divi’s Labs: Improved growth visibility for custom synthesis, but valuation rich

9.42 am | 10 Nov 2020 |  Source: Moneycontrol.com

Divi's Labs result re-emphasise the fact that the global trend of de-risking supply chains away from China is adding to order enquires and product...

Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market

1.38 pm | 09 Nov 2020 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Divi's Laboratories with a target price of Rs 3515 in its research report dated November 08,...

Buy Divi's Laboratories; target of Rs 4205: ICICI Direct

11.52 am | 09 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4205 in its research report dated Nov...

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.